Coverage Considerations Saxenda: Longer FDA approval history (2014) may mean better coverage on some plans Step therapy: Some plans require trying Saxenda before approving Zepbound Zepbound: Superior efficacy (20.9% vs ~8% weight loss) may justify coverage even if more expensive Cash Pay Options If insurance doesn't cover your preferred option: Zepbound via LillyDirect: $299$449/month (vials, Dec 2025) Saxenda: ~$1,400/month retail
Looking for more ways to boost firmness and radiance with SkinCeuticals
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
This article covers why GLP-1 medications cause constipation, what the probiotic literature actually shows on transit time and constipation symptoms, and how to evaluate any probiotic claim aimed at GLP-1 users
Tocopherol + Tocopheryl Acetate (Vitamin E): Antioxidants that support skin protection
Integration of AI and experimental verification With the rapid advancement of AI, an increasing number of studies now emphasize integrating AI-based predictions with experimental validation to enhance the reliability and biological relevance of results